Supreme Court denies Teva stay in Copaxone patent fight

Reuters News
|
Posted: Apr 18, 2014 4:16 PM

WASHINGTON (Reuters) - U.S. Supreme Court Chief Justice John Roberts on Friday denied a request by Teva Pharmaceutical Industries Ltd that would have prevented a lower court ruling from going into effect while the court considers an appeal in a patent fight over Teva's top-selling multiple sclerosis drug Copaxone.

The decision could help pave the way for generic competitors to go on the market as soon as next month.

Recommended
The Late Hit on Judge Kavanaugh
Pat Buchanan

(Reporting by Lawrence Hurley; Editing by Sandra Maler)